Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Hepatocarcinoma · Lung Cancer · Melanoma · Renal Cancer · Head and Neck Cancer · Pancreas Cancer · Ovarian Cancer · Colo-rectal Cancer · Cervical Cancer · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Second Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China
Contact: Study coordinator (Zhenfeng Zhang, MD,PhD) · zhangzhf@gzhmu.edu.cn · 02034153532

Study leads

Zhenfeng Zhang, MD,PhD
Principal Investigator
Second Affiliated Hospital of Guangzhou Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Clear Cell Renal Cell Cancer (ccRCC) · Urothelial Carcinoma (UC) · Colorectal Cancer

Abroad (travel likely)Recruiting

Beijing, China

Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United Kingdom · Cambridge, United Kingdom

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Solid Tumor, Adult · Triple Negative Breast Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · La Jolla, United States